- Kazia Therapeutics Announces $2 Million Registered Direct Offering
- Refeyn Launches KaritroMP for Rapid and Reproducible Characterization of Large Viral Vectors
- Savage Medical Exits Stealth With Over $3 Million to Enable Minimally Invasive Colorectal Tumor Removal
- Inspira Technologies Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
- Function of Research Liquids in Biomedical Researches
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.
Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.
Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.
"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"
Amber Therapeutics Announces Successful First-in-human Implants of Amber-UI: An Intelligent, Closed-loop Bioelectrical Therapy for Urge and Mixed Urinary Incontinence
Amber-UI is the first fully implantable closed-loop bioelectrical therapy in clinical development for UI, which is made possible by being able to access and target the pudendal nerve – the nerve that directly controls continence – through a novel, minimally invasive surgical procedure.
Inspira Technologies Granted Patent by U.S. Patent Office for the INSPIRA(TM) ART System’s Convertible Dual Lumen Cannula Device and Method of Use
Inspira Technologies expects to integrate the convertible dual lumen cannula with additional Inspira products in the future. In addition, the Company may consider the future commercialization of the convertible dual lumen cannula separately as a disposable product.
Accuray Announces First Patient Treatments in New Zealand With the CyberKnife ® System, the World’s Only Robotic Radiation Therapy Delivery Device
The ARO medical care team selected the latest generation CyberKnife S7 ™ System to provide stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) to patients more efficiently, minimizing the time they spend in daily treatments and maximizing the number of New Zealand cancer patients they can treat each day.
SynerFuse Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study
“So far in the study, the SynerFuse procedure has been efficient and straightforward to perform,” said Lall. “The industry has seen the efficacy of DRG stimulation for patients with chronic pain, and it is very exciting to be able to study incorporating it earlier in the treatment process for these patients in an attempt to reduce their pain levels and needs for opioids. I believe this will become widely adopted in spine surgery.”
Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future
Synergy Health Network’s $100 Mil Expansion Starts with Crowdfunding via Rialto Markets
Synergy Health Network is giving investors the chance to back its expansion plans after teaming up with Rialto Markets to utilise the award-winning broker-dealer’s crowdfunding platform and infrastructure for a $1 million Reg CF raise to launch Synergy’s four-year growth mission.
Deciphex Raises $11.5M in Series B Funding Led by ACT Venture Capital
Deciphex will leverage the funding to continue driving global growth and to consolidate its position as a leader in revolutionising clinical and non-clinical pathology
Industry Expert Byline
Reimagining CRM: What’s Next for Medtech Commercial Success | By Akshay Kapadia, CEO and Founder, Conexus Solutions, Inc.
Success depends on more than just choosing the right CRM platform; it requires aligning that platform with optimized business processes, a clear data strategy, and long-term commercial goals. When all of these elements work together, the CRM platform becomes a powerful tool to support growth, innovation, and sustained value.
Revvity Expands Access to Base Editing Technology with Aim to Accelerate Discovery to Cure
Michelle Fraser, head of cell and gene therapy at Revvity, underscores the importance of providing broad access to this technology: “Base editing has been extensively demonstrated in numerous studies to safely and precisely control the correction of single base changes at multiple target sites, simultaneously. This streamlined approach simplifies complex multi-gene editing, holding great promise for the development of new cell therapies targeting rare inherited genetic diseases, cancer, and in the creation of universal donor cells as the foundation of allogeneic cell therapies.”
PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial
The EV-302 study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS), compared to chemotherapy. An Independent Data Monitoring Committee determined that OS crossed the pre-specified efficacy boundary at interim analysis. The safety results of the combination are consistent with those of enfortumab vedotin in combination with pembrolizumab previously reported in cisplatin-ineligible patients with la/mUC.
Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies
EarlySense Sells IP To Hillrom for $30M+ – Focuses on Virtual/Home Patient Monitoring
“We set out to save lives and improve care by implementing AI-based contact-free patient monitoring in healthcare facilities across the globe,” said Matt Johnson, CEO of EarlySense.
Olympus Corporation to Acquire Quest Photonic Devices B.V.
Olympus Corporation announced that it has entered into an agreement to acquire Quest Photonic Devices B.V. for up to EUR50 million including milestone payments to strengthen its surgical endoscopy capabilities.
FDA Medical Device Updates
Our Experts - Byline Articles
Medical Imaging Technologies and Their Impact on Modern Healthcare
Healing Headlines, Transforming Lives: Hospitals in the News
Philips and Gibraltar Health Authority Announce 16-year Strategic Partnership
For the first time, patients will no longer need to travel abroad for treatment of acute cardiac diseases, as the Gibraltar Health Authority prepares to provide local coronary angiography and angioplasty services in a new interventional cardiac suite.
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
Non-Profit News
Executives on the Move
Healthcare - Understanding the Business Side of the Industry and Its Implications
Healthcare Careers and Opportunities in the Evolving Medical Field
Nurses Corner: A Dedicated Space for Professional Insights and Resources
